lipid
raft
involv
life
cycl
mani
virus
studi
show
lipid
raft
also
play
import
role
life
cycl
sever
acut
respiratori
syndrom
sar
coronaviru
cov
cholesterol
deplet
pretreat
vero
cell
methylbcyclodextrin
mbcd
inhibit
product
sarscov
particl
releas
infect
cell
inhibit
prevent
addit
cholesterol
cultur
medium
indic
reduct
viru
particl
releas
caus
loss
cholesterol
cell
membran
contrast
cholesterol
deplet
postentri
stage
h
postinfect
caus
limit
effect
viru
particl
releas
northern
blot
analysi
reveal
level
viral
mrna
significantli
affect
pretreat
mbcd
treatment
h
postinfect
interestingli
appar
evid
coloc
angiotensin
convert
enzym
lipid
raft
membran
vero
cell
obtain
result
suggest
lipid
raft
could
contribut
sarscov
infect
earli
replic
process
vero
cell
lipid
raft
special
microdomain
cell
membran
sphingolipid
cholesterol
associ
protein
enrich
mani
biolog
event
biosynthet
traffic
apoptosi
signal
transduct
pathway
requir
integr
raft
microdomain
membran
structur
isol
basi
insolubl
deterg
triton
c
accumul
evid
suggest
mani
pathogen
especi
virus
requir
lipid
raft
multipl
stage
life
cycl
human
immunodefici
viru
semliki
forest
viru
human
enterovirus
requir
lipid
raft
bind
intern
viru
particl
host
cell
interestingli
receptor
coreceptor
certain
virus
report
associ
lipid
raft
cell
membran
heat
shock
protein
dengu
viru
integrin
human
cytomegaloviru
raft
microenviron
also
provid
platform
viru
assembl
well
viral
releas
case
influenza
viru
exampl
cytoplasm
tail
transmembran
domain
one
viral
protein
hemagglutinin
facilit
bind
anoth
viral
protein
matrix
detergentresist
lipid
raft
similarli
lipid
raft
also
shown
necessari
assembl
sendai
viru
sever
envelop
virus
contain
lipid
raft
membran
cholesterol
deplet
mbcd
shown
inactiv
permeabil
virion
suggest
import
virusassoci
cholesterol
infect
furthermor
nef
protein
report
abl
increas
infect
via
lipid
raft
therefor
lipid
raft
could
play
import
role
viru
replic
also
viral
pathogenesi
recent
requir
lipid
raft
replic
coronavirus
cov
murin
hepat
viru
mhv
report
cholesterol
level
cell
membran
determin
suscept
mhv
infect
experi
reveal
mhv
requir
lipid
raft
viru
entri
fusion
viru
releas
mhv
receptor
carcinoembryon
antigenrel
cell
adhes
molecul
socal
shown
present
lipid
raft
sever
acut
respiratori
syndrom
sar
cov
newli
emerg
member
famili
coronavirida
caus
sever
infecti
respiratori
diseas
angiotensin
convert
enzym
found
receptor
sarscov
sarscov
replic
well
vero
cell
produc
larg
amount
progeni
particl
although
recent
report
show
sarscov
envelop
protein
partial
local
lipid
raft
transmembran
domain
requir
mainten
membran
permeabil
activ
direct
evid
demonstr
signific
lipid
raft
replic
sarscov
present
studi
examin
signific
lipid
raft
replic
sarscov
vero
cell
data
obtain
reveal
lipid
raft
cell
membran
requir
earli
stage
replic
sarscov
vero
cell
line
use
propag
sarscov
strain
vero
cell
maintain
mem
gibco
brl
supplement
fetal
bovin
serum
fb
icn
flow
uml
penicillin
mgml
streptomycin
gibco
brl
complet
medium
passag
everi
day
inoculum
sarscov
cultur
medium
infect
vero
cell
collect
day
postinfect
viru
titer
determin
micropl
vero
cell
result
express
tissu
cultur
infecti
dose
tcid
ml
use
karber
method
vero
cell
seed
micropl
left
untreat
pretreat
mm
mbcd
sigma
min
c
describ
previous
wash
three
time
phosphatebuff
salin
pb
cell
cultur
complet
medium
incub
appropri
time
posttreat
cell
harvest
lysat
assay
cholesterol
concentr
use
amplex
red
cholesterol
assay
system
molecular
probe
cell
viabil
assay
vero
cell
seed
micropl
left
untreat
pretreat
mbcd
similarli
describ
incub
appropri
time
posttreat
cell
subject
viabil
assay
use
cell
prolifer
assay
kit
chemicon
intern
examin
number
viabl
cell
measur
overal
activ
mitochondri
dehydrogenas
sampl
formazan
dye
produc
viabl
cell
quantifi
measur
absorb
dye
solut
nm
cell
seed
micropl
either
left
untreat
treat
variabl
concentr
mbcd
min
c
incub
h
sarscov
multipl
infect
moi
altern
cell
first
incub
sarscov
h
treat
mm
mbcd
h
adsorpt
infect
cell
wash
three
time
pb
cultur
mem
supplement
fb
cholesterol
replenish
cell
first
pretreat
mm
mbcd
min
describ
follow
supplement
mgml
cholesterol
sigma
mem
h
c
three
wash
pb
cell
subject
mockinfect
infect
sarscov
investig
viru
yield
cell
incub
h
cultur
supernat
subject
viru
titrat
vero
cell
describ
analys
viral
antigen
express
immunofluoresc
assay
perform
describ
previous
briefli
vero
cell
chamber
left
untreat
treat
mbcd
infect
h
infect
h
postinfect
hpi
cell
harvest
wash
pb
fix
paraformaldehyd
min
room
temperatur
fix
cell
react
monoclon
antibodi
mab
antisarscov
spike
protein
northern
blot
analysi
sarscov
mrna
carri
describ
previous
modif
briefli
uninfect
infect
vero
cell
either
untreat
treat
mbcd
harvest
total
rna
extract
trizol
invitrogen
rna
mg
subject
agaros
gel
presenc
formaldehyd
blot
onto
membran
amersham
plasmid
encod
fulllength
nucleocapsid
protein
n
gene
name
pefbossarsn
construct
introduc
fulllength
n
gene
pefbo
vector
one
fragment
gene
prepar
probe
restrict
enzym
digest
pefbossarsn
plasmid
use
nhei
xhoi
dna
probe
ng
denatur
c
min
label
alkalin
phosphatas
use
alkpho
label
detect
system
ge
healthcar
life
scienc
blot
prehybrid
hybrid
buffer
c
h
subject
hybrid
ngml
alkalin
phosphataselabel
dna
probe
c
h
extens
wash
blot
develop
cdpstar
chemifluoresc
detect
system
alkpho
label
detect
system
control
rna
input
probe
dehydrogenas
gapdh
also
prepar
revers
transcriptasepcr
use
superscript
iii
revers
transcriptas
invitrogen
rna
isol
uninfect
vero
cell
primer
amplif
follow
acc
aca
gtc
cat
gcc
atc
tcc
acc
acc
ctg
ttg
ctg
pcr
product
ng
label
alkalin
phosphatas
use
hybrid
gapdh
mrna
procedur
similar
describ
investig
whether
cholesterol
deplet
affect
express
surfac
vero
cell
cell
either
left
untreat
pretreat
variabl
concentr
mbcd
c
min
wash
pb
cell
detach
treatment
mm
edta
detach
cell
react
antihuman
mab
r
system
reaction
fluoresc
isothiocyan
conjug
goat
antimous
igg
cell
subject
flow
cytometri
analysi
vero
cell
adsorpt
sarscov
moi
h
c
subject
membran
flotat
assay
accord
previous
describ
procedur
minor
modif
briefli
cell
wash
three
time
icecold
pb
subsequ
lyse
ml
tne
buffer
mm
trisehcl
ph
mm
nacl
mm
edta
contain
triton
lysat
homogen
passag
needl
syring
time
subsequ
centrifug
rpm
min
c
remov
cell
nuclei
debri
postnuclear
supernat
incub
c
h
mix
ml
icecold
wv
sucros
tne
buffer
mixtur
put
bottom
beckman
ultracentrifug
tube
overlaid
ml
icecold
wv
sucros
tne
buffer
ml
icecold
wv
sucros
tne
buffer
sampl
centrifug
g
c
h
final
fraction
prepar
top
bottom
tube
examin
presenc
western
blot
analysi
describ
western
blot
analysi
fraction
obtain
membran
flotat
assay
mix
vv
ratio
concentr
nonreduc
sodium
dodecyl
sulfateepolyacrylamid
gel
electrophoresi
sampl
buffer
fraction
ml
subject
sodium
dodecyl
sulfateepolyacrylamid
gel
electrophoresi
western
blot
incub
antihuman
mab
r
system
antihuman
transferrin
receptor
tfr
mab
zyme
laboratori
invitrogen
polyclon
antibodi
chemicon
intern
c
h
blot
wash
three
time
pb
contain
pbst
incub
horseradish
peroxidaseconjug
goat
antimous
antirabbit
igg
jackson
immunoresearch
laboratori
h
room
temperatur
final
protein
band
visual
use
ecl
plu
protein
detect
system
amersham
dotblot
analysi
pvdf
membran
immobilonp
millipor
pretreat
methanol
follow
soak
pbst
min
ten
microlit
sampl
fraction
dotblot
membran
airdri
membran
block
bovin
serum
albumin
pbst
room
temperatur
h
gangliosid
detect
cholera
toxinperoxidas
sigma
mgml
min
room
temperatur
follow
wash
time
pbst
membran
develop
ecl
plu
protein
detect
system
describ
investig
kinet
chang
cholesterol
level
vero
cell
cell
either
left
untreat
treat
mm
mbcd
cell
collect
treatment
h
posttreat
cell
lysat
prepar
subject
amplex
red
cholesterol
assay
shown
fig
cholesterol
level
decreas
soon
treatment
subsequ
level
increas
gradual
reach
normal
level
h
posttreat
thu
treatment
vero
cell
mm
mbcd
abl
remov
cholesterol
cell
describ
report
exclud
possibl
concentr
mbcd
might
caus
cell
toxic
vero
cell
cell
prolifer
assay
perform
h
posttreat
shown
fig
appar
differ
cell
number
treat
untreat
vero
cell
indic
induct
cytotox
concentr
mm
mbcd
vero
cell
left
untreat
treat
n
pretreat
mm
mm
mbcd
min
c
infect
sarscov
variou
moi
ie
infect
cell
cultur
h
viru
product
result
cultur
fluid
assay
titrat
vero
cell
describ
section
result
express
tcid
per
ml
shown
fig
mbcd
treatment
impair
viru
product
dosedepend
manner
suggest
cholesterol
necessari
replic
sarscov
vero
cell
impair
viru
product
appar
cell
infect
lower
moi
sarscov
confirm
import
cholesterol
sarscov
replic
vero
cell
deplet
cellular
cholesterol
pretreat
mm
mbcd
min
cholesterol
ad
back
treat
cho
viru
product
replenish
similarli
investig
fig
cholesterol
replenish
could
restor
viru
product
case
evidenc
similar
level
viral
product
untreat
cell
result
suggest
reduct
viru
product
specif
due
cholesterol
deplet
effect
revers
next
attempt
find
whether
deplet
lipid
raft
earli
stage
sarscov
life
cycl
inhibitori
effect
viru
product
vero
cell
infect
sarscov
incub
h
cell
treat
mbcd
treat
hpi
viru
product
cultur
fluid
examin
shown
fig
treatment
viru
entri
mild
effect
suggest
cholesterol
mainli
requir
earli
stage
sarscov
replic
next
amount
viral
mrna
insid
cell
hpi
examin
northern
blot
analysi
shown
fig
hpi
even
moi
level
viral
mrna
significantli
decreas
vero
cell
treat
mbcd
min
infect
treat
compar
untreat
cell
treat
n
suggest
viru
entri
reduc
deplet
cholesterol
cell
membran
addit
pretreat
untreat
cell
similarli
infect
hpi
cell
treat
mbcd
treat
infect
cell
incub
anoth
h
viral
mrna
cell
compar
found
hpi
cell
pretreat
mbcd
show
significantli
lower
level
mrna
untreat
cell
type
cell
show
much
higher
level
viral
mrna
hpi
indic
mrna
synthesi
proceed
success
treatment
mbcd
hpi
caus
moder
effect
suggest
reduct
viral
mrna
synthesi
may
result
blockag
earli
process
start
synthesi
viral
messag
addit
immunofluoresc
perform
examin
viral
antigen
express
level
use
mab
sarscov
protein
clear
reduct
viral
antigen
express
hpi
observ
cell
pretreat
mm
mbcd
infect
moi
data
shown
flow
cytometr
analysi
reveal
cholesterol
extract
mbcd
treatment
could
reduc
express
level
cell
surfac
dosedepend
manner
fig
suggest
may
associ
lipid
raft
therefor
perform
membran
flotat
assay
examin
local
vero
cell
sarscov
adsorpt
shown
fig
upper
four
panel
mainli
detect
fraction
tfr
use
nonraft
marker
also
enrich
marker
lipid
raft
fraction
shown
local
detergentresist
membran
fraction
enrich
data
suggest
directli
associ
lipid
raft
next
examin
possibl
shift
locat
viru
adsorpt
fig
lower
two
panel
howev
appar
shift
raft
area
observ
suggest
viru
bind
could
trigger
reloc
raft
membran
lipid
raft
vero
cell
membran
shown
first
time
necessari
replic
sarscov
deplet
cholesterol
mbcd
pretreat
significantli
inhibit
viru
product
especi
cell
infect
low
moi
subsequ
experi
reveal
inhibit
probabl
caus
blockag
earli
step
viru
replic
investig
viru
infect
reveal
cholesterol
deplet
impair
viru
product
inhibitori
effect
could
revers
replenish
cholesterol
impli
direct
involv
cholesterol
process
extent
inhibit
seem
depend
moi
although
find
might
result
long
incub
time
need
viru
infect
assay
sinc
cholesterol
level
cell
membran
shown
abl
gradual
increas
similar
level
untreat
cell
h
posttreat
suscept
cell
sarscov
infect
might
also
recov
would
enabl
next
round
infect
especi
infect
cell
higher
moi
could
reason
less
signific
effect
mbcd
pretreat
cell
infect
higher
moi
especi
evalu
effect
mbcd
viru
infect
cultur
h
respect
total
rna
extract
subject
northern
blot
analysi
dna
probe
sarscov
n
gene
control
rna
input
amount
rna
sampl
subject
northern
blot
analysi
gapdh
gene
express
sarscov
shown
abl
enter
vero
cell
fusion
cell
membran
h
adsorpt
studi
investig
whether
lipid
raft
play
role
post
entri
step
treat
cell
hpi
result
viru
particl
releas
viru
antigen
express
reveal
treat
caus
littl
inhibit
sarscov
replic
suggest
cholesterol
mainli
requir
earli
stage
analysi
viru
mrna
express
northern
blot
suggest
extent
viru
entri
greatli
reduc
deplet
cholesterol
cell
membran
indic
cholesterol
requir
earli
stage
viru
replic
mani
virus
util
receptor
local
raft
microdomain
host
cell
success
entri
therefor
examin
express
level
mbcd
treatment
flow
cytometri
result
show
mbcd
treatment
slightli
decreas
express
level
cell
membran
dosedepend
manner
thu
might
associ
lipid
raft
cell
membran
howev
membran
flotat
assay
show
coloc
lipid
raft
vero
cell
either
uninfect
adsorb
sarscov
result
may
consist
anoth
report
show
raftcoloc
cho
cell
case
major
receptor
local
lipid
raft
wherea
coreceptor
directli
associ
lipid
raft
howev
function
requir
cholesterol
target
cell
membran
consequ
discrep
obtain
flow
cytometri
membran
flotat
assay
studi
may
explain
possibl
presenc
unknown
host
factor
could
local
lipid
raft
play
role
viru
entri
sarscov
known
util
endocytosi
fusion
process
enter
host
cell
pathway
could
impair
extract
cholesterol
cell
membran
detail
experi
would
necessari
determin
pathway
block
mbcd
treatment
result
seem
consist
find
obtain
mhv
lipid
raft
membran
structur
shown
requir
entri
viral
particl
releas
mhv
cellular
receptor
mhv
enrich
raftcontain
membran
cholesterol
deplet
effect
bind
viru
cell
howev
viru
entri
virusinduc
fusion
impair
suggest
cholesterol
might
requir
postbind
stage
case
anoth
coronaviru
human
coronaviru
cellular
receptor
shown
local
lipid
raft
coloc
occur
physic
condit
howev
deplet
cholesterol
pretreat
mbcd
reduc
coloc
without
signific
effect
bind
viru
cell
deplet
cholesterol
mbcd
significantli
reduc
redistribut
subsequ
infect
present
studi
found
lipid
raft
requir
earli
stage
sarscov
replic
cholesterol
may
requir
postbind
stage
found
mhv
detail
studi
need
understand
mechan
inhibit
sarscov
life
cycl
well
possibl
applic
find
design
antisarscov
therapi
